BSE filing, NSE: DSINVEST. Summary written from the filing by ALFA Finder's alert engine.
Dalal Street Investments Ltd: key numbers
- Share price
- ₹373.00
- Market cap
- ₹11.75 Cr
- Revenue (annual)
- ₹0.61 Cr
- Net profit (annual)
- ₹-0.01 Cr
- P/E (TTM)
- -20.5×Sector 19.7×
- Promoter holding
- 74.68%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dalal Street Investments Ltd
All →Dalal Street Investments Q2 FY27 Results: Net Loss of ₹0.3 Cr
Dalal Street Investments Ltd reported a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
Dalal Street Investments Board Meeting Date
Dalal Street Investments intimates a board meeting dated October 28, 2026. The agenda covers unaudited half-yearly results for the period ended September 2026.
Dalal Street Investments Annual General Meeting
Dalal Street Investments held its 49th AGM on 22 Sep 2026 via视频会议. Routine matters – adoption of FY26 audited financials and re-appointment of a retiring director – were approved.
Dalal Street Investments Annual Report
Dalal Street Investments Limited has filed its 49th Annual Report for FY 2025-26, including the notice for the upcoming Annual General Meeting scheduled for September 22, 2026.
Dalal Street Investments Annual General Meeting
Dalal Street Investments Limited will hold its 49th Annual General Meeting on September 22, 2026. The board approved the Annual Report and fixed the book closure dates.
Dalal Street Investments Board Meeting Date
Dalal Street Investments Limited will hold a board meeting on August 20, 2026, to discuss the AGM and Annual Report.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.